Novel Fredericamycin Variant Overproduced by a Streptomycin-resistant <i>Streptomyces</i> <i>albus</i> subsp. <i>chlorinus</i> Strain

Novel Fredericamycin Variant Overproduced by a Streptomycin-resistant <i>Streptomyces</i> <i>albus</i> subsp. <i>chlorinus</i> Strain

Streptomycetes are an important source of natural products potentially applicable in the pharmaceutical industry. Many of these drugs are secondary metabolites whose biosynthetic genes are very often poorly expressed under laboratory cultivation conditions. In many cases, antibiotic-resistant mutant...

Full description

Bibliographic Details
Main Authors: Marta Rodríguez Estévez, Maksym Myronovskyi, Birgit Rosenkränzer, Thomas Paululat, Lutz Petzke, Jeanette Ristau, Andriy Luzhetskyy
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Marine Drugs
Subjects:
antitumor
fredericamycin
overproduction
secondary metabolites
streptomycetes
streptomycin-resistant
Online Access:https://www.mdpi.com/1660-3397/18/6/284

Internet

https://www.mdpi.com/1660-3397/18/6/284

Similar Items